Cargando…
DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice
Influenza vaccination practice, which is based on neutralizing antibodies, requires being able to predict which viral strains will be circulating. If an unexpected strain, as in the 1997 H5N1 Hong Kong outbreak, or even a pandemic emerges, appropriate vaccines may take too long to prepare. Therefore...
Autores principales: | Epstein, Suzanne L., Tumpey, Terrence M., Misplon, Julia A., Lo, Chia-Yun, Cooper, Lynn A., Subbarao, Kanta, Renshaw, Mary, Sambhara, Suryaprakash, Katz, Jacqueline M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732511/ https://www.ncbi.nlm.nih.gov/pubmed/12141964 http://dx.doi.org/10.3201/eid0808.010476 |
Ejemplares similares
-
Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
por: Price, Graeme E., et al.
Publicado: (2010) -
Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1
por: Tompkins, Stephen Mark, et al.
Publicado: (2007) -
The ferret as a model organism to study influenza A virus infection
por: Belser, Jessica A., et al.
Publicado: (2011) -
Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice
por: García, Mayra, et al.
Publicado: (2016) -
Immunosenescence and Influenza Vaccine Efficacy
por: Sambhara, Suryaprakash, et al.
Publicado: (2009)